Concord Medical Services Stock Analysis

CCM Stock  USD 0.55  0.04  6.27%   
Concord Medical Services is fairly valued with Real Value of 0.57 and Hype Value of 0.58. The main objective of Concord Medical stock analysis is to determine its intrinsic value, which is an estimate of what Concord Medical Services is worth, separate from its market price. There are two main types of Concord Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Concord Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Concord Medical's stock to identify patterns and trends that may indicate its future price movements.
The Concord Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Concord Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Concord Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Concord Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Concord Stock Analysis Notes

About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.49. Concord Medical Services last dividend was issued on the 23rd of December 2015. The entity had 11384:1000 split on the 16th of January 2014. Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people. For more info on Concord Medical Services please contact Jianyu Yang at 86 10 5903 6688 or go to https://www.concordmedical.com.

Concord Medical Services Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Concord Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Concord Medical Services or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Concord Medical generated a negative expected return over the last 90 days
Concord Medical has high historical volatility and very poor performance
Concord Medical has some characteristics of a very speculative penny stock
Concord Medical has high likelihood to experience some financial distress in the next 2 years
The company has 3.24 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Concord Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Concord Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Concord Medical Services sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Concord to invest in growth at high rates of return. When we think about Concord Medical's use of debt, we should always consider it together with cash and equity.
The entity reported the last year's revenue of 472.08 M. Reported Net Loss for the year was (768.99 M) with loss before taxes, overhead, and interest of (152.41 M).
Concord Medical Services has about 157.39 M in cash with (216.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 18.0% of Concord Medical shares are held by company insiders
Latest headline from businesswire.com: GCT Semiconductor Becomes a Publicly Traded Company After Completing Business Combination with Concord Acquisition Corp III, Will Commence Trading on NYSE Under Ticker Symbol GCTS

Concord Medical Services Upcoming and Recent Events

Earnings reports are used by Concord Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Concord Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
17th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Concord Largest EPS Surprises

Earnings surprises can significantly impact Concord Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-03-31
2013-12-310.060.05-0.0116 
2010-08-18
2010-06-300.090.10.0111 
2010-05-27
2010-03-310.070.06-0.0114 
View All Earnings Estimates

Concord Medical Thematic Classifications

In addition to having Concord Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

Concord Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Concord Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Concord Medical Services backward and forwards among themselves. Concord Medical's institutional investor refers to the entity that pools money to purchase Concord Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Renaissance Technologies Corp2023-12-31
47.9 K
Rhumbline Advisers2023-12-31
5.5 K
Blackrock Inc2023-12-31
143
Ubs Group Ag2023-12-31
101
Note, although Concord Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Concord Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 24.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Concord Medical's market, we take the total number of its shares issued and multiply it by Concord Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Concord Profitablity

Concord Medical's profitability indicators refer to fundamental financial ratios that showcase Concord Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Concord Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Concord Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Concord Medical's profitability requires more research than a typical breakdown of Concord Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (0.76) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.75) %, which entails that for every $100 of revenue, it lost $0.75.
Last ReportedProjected for 2024
Return On Capital Employed(0.11)(0.12)
Return On Assets(0.15)(0.14)
Return On Equity 0.37  0.39 

Management Efficiency

Concord Medical Services has Return on Asset of (0.0498) % which means that on every $100 spent on assets, it lost $0.0498. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3142) %, meaning that it generated no profit with money invested by stockholders. Concord Medical's management efficiency ratios could be used to measure how well Concord Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of March 2024, Return On Equity is likely to grow to 0.39, while Return On Capital Employed is likely to drop (0.12). At this time, Concord Medical's Intangible Assets are very stable compared to the past year. As of the 28th of March 2024, Total Current Assets is likely to grow to about 758 M, while Other Assets are likely to drop about 26.2 M.
Last ReportedProjected for 2024
Price Book Value Ratio(0.30)(0.29)
Enterprise Value Multiple(7.08)(6.72)
Price Fair Value(0.30)(0.29)
The analysis of Concord Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Concord Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Concord Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
(0.21)

Technical Drivers

As of the 28th of March, Concord Medical shows the Mean Deviation of 5.4, standard deviation of 8.91, and Risk Adjusted Performance of (0.02). Concord Medical Services technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Concord Medical Services, which can be compared to its rivals. Please confirm Concord Medical Services variance and value at risk to decide if Concord Medical Services is priced correctly, providing market reflects its regular price of 0.553 per share. As Concord Medical Services is a penny stock we also strongly suggest to validate its jensen alpha numbers.

Concord Medical Services Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Concord Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Concord Medical Services. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Concord Medical Predictive Daily Indicators

Concord Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Concord Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Concord Medical Forecast Models

Concord Medical's time-series forecasting models are one of many Concord Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Concord Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Concord Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Concord Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Concord shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Concord Medical. By using and applying Concord Stock analysis, traders can create a robust methodology for identifying Concord entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin(2.05)(1.94)
Operating Profit Margin(1.28)(1.22)
Net Loss(1.87)(1.78)
Gross Profit Margin(0.37)(0.35)

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Concord Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Concord Stock analysis

When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.49)
Revenue Per Share
14.017
Quarterly Revenue Growth
0.972
Return On Assets
(0.05)
Return On Equity
(0.31)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.